Skip to main content

We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. States
  3. Delaware
  4. Weight Loss
Telehealth treatment comparison background
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onOctober 09, 2026

Weight Loss Telehealth in Delaware 14 Providers Compared for 2026

In Delaware, you can get weight loss medication prescribed online without an in-person visit, making telehealth access faster and easier.

Fast Approval
Free Shipping
Exclusive Coupons
Online Prescription
Compare weight loss treatment providers in Delaware

Key Takeaways

Best weight loss telehealth in Delaware: Medvi (9.2/10), whose compounded semaglutide is $179 for your first month and $299/month for refills after that, and Hims (9.4/10) if you want weight loss handled alongside other conditions. Delaware's full insurance parity means your telehealth visits are covered at the same rate as in-person appointments, so check your plan before paying out-of-pocket. You'll find 14 weight loss providers available in the state as of 2026.

Who This Is For

This is for
  • You prefer choosing from a wide range of providers - Delaware has 14 options available to you.
  • You're comfortable giving consent before your telehealth visit, as Delaware requires before treatment begins.
Not for
  • Delaware requires prescriptions from a licensed Delaware provider, so out-of-state scripts won't be accepted here.
  • The FDA-approved labeling for Wegovy and Zepbound covers weight reduction in adults with a BMI of 30 or higher, and in adults with a BMI of 27 or higher who have at least one weight-related condition such as type 2 diabetes or high blood pressure. If you are near either number, ask a licensed provider where you fall before choosing a platform.
  • If you are pregnant or planning a pregnancy, the Wegovy label directs you to stop semaglutide once pregnancy is recognized and two months before a planned pregnancy, so raise it at intake.
  • If you are breastfeeding, ask the provider what the label for the specific medication says, because the labels differ.
  • If you have a history of disordered eating, tell the provider at intake, because it is part of what a prescriber weighs before starting a weight loss medication.
  • If you have had bariatric surgery or are considering it, tell the provider at intake, because it changes what a prescriber will consider.
  • A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
  • If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.

These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.

User Preferences & Delaware Availability

TrimRx is the top choice for 25% of users comparing weight loss providers on ManyTreatments in 2026, followed by Ro (16%) and Hers (14%).

16 licensed telehealth providers offer weight loss programs to Delaware residents. Delaware requires prescriptions to be written by a licensed in-state provider.

Medical Disclaimer: Content is for informational purposes only - not medical advice. Consult a licensed healthcare provider before any treatment. Learn more

Best Value
1
Ro logo

Wegovy® From $149/mo Plus Membership From $74/mo - Free Insurance Check

  • Full GLP-1 suite: Zepbound®, Wegovy® pill and pen, semaglutide and more
  • Free insurance check shows what your plan covers before you pay
  • Tirzepatide (Zepbound®) averaged up to 20.9% body weight loss in the 72-week SURMOUNT-1 trial; individual results vary
  • On-demand provider coaching and support, 100% online
LegitScript lists Ro as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Most Popular
2
Medvi logo

First Month $179, Then $299/mo With No Membership Fee

  • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
3
Strut logo

Start for Free - Free MD Visit, Follow-Up Care & Shipping

  • Compounded injectable semaglutide prescribed by U.S.-licensed physicians. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free online MD visit and free follow-up care included
  • Free shipping - fill through Strut's pharmacy network or your local pharmacy
  • Your Strut doctor manages your dosage increase plan as treatment progresses
Strut displays LegitScript certificate 11142478, checked September 19, 2026Cert. 11142478September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
4
Fridays logo

Compounded Semaglutide From $150/mo on Prepaid Plans

  • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
5
Sprout Health logo

Compounded Semaglutide From $199/mo - Free 2-Minute Quiz

  • Compounded semaglutide and tirzepatide from $199/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Prescribed by US-licensed clinicians with personalized dosing - no waiting room
  • Ships from a US pharmacy in discreet, refrigerated packaging
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
6
Eden logo

Start for Just $129 First Month. Same Price Every Dose

  • Compounded semaglutide & tirzepatide custom dosed. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free consults with US doctors, 24/7 messaging
  • Fast discreet shipping, cancel anytime no contracts
  • Ongoing optimization for your health goals
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
7
HealthRx logo

Compounded GLP-1 From $99/mo - Full Refund If You Are Not Approved

  • Compounded semaglutide & tirzepatide GLP-1, from $99/mo on the 12-month plan ($133/mo for 3 months)
  • No insurance needed - full refund if a licensed provider doesn't approve you
  • Physician-supervised online intake, and HealthRx displays LegitScript certification seal 50087439, which we checked with LegitScript on September 19, 2026
  • Ships from US pharmacies in 24-48 hours with fast, free delivery
HealthRx displays LegitScript certificate 50087439, checked September 19, 2026Cert. 50087439September 19, 2026
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
View 7 More Weight Loss Providers
8
Peter MD logo

Starting at $209/mo - $100 Off Your First Month

  • Compounded semaglutide option available. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Board-certified obesity medicine specialists
  • All supplies & shipping included in price
  • No surprise bills - transparent pricing
9.5
ExceptionalScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
9
Skinny.Rx logo

25% Lower Prices on All GLP-1s - Semaglutide From $149.25/mo

  • Compounded injectable semaglutide from $149.25/mo, tirzepatide tablets from $224.25/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • FDA-approved Wegovy® and other GLP-1s available, plus daily oral options via membership
  • Clinician-guided care, not just a prescription - ongoing dose adjustments and provider check-ins
  • App with care team support, medication reminders and weight trend tracking
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
10
Hers logo

FDA-Approved GLP-1s From $149/mo Plus Required $149/mo Membership

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Personal plan with ongoing care from day 1 via membership
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Our Top Choice
11
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
12
Hims logo

FDA-Approved GLP-1s From $149/mo Plus Required $149/mo Membership

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Personal plan with on-demand care from day 1 via membership
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
13
Shed logo

Semaglutide From $159/mo - 120-Day Refund If You Don't Lose 5%

  • Compounded semaglutide as low as $159/mo, tirzepatide from $239/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • 120-day money-back guarantee - refund if you don't lose 5%, per Shed's terms
  • 100% online visit and checkout - prescription shipped straight to your door
  • Health coaching support included alongside your GLP-1 program
Shed displays LegitScript certificate 44256860, checked September 19, 2026Cert. 44256860September 19, 2026
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
14
Sesame Care logo

Wegovy Pill From $149/mo Plus Care Plans From $59/mo - Same-Day Visits

  • Cash-pay GLP-1 medications as low as $149/mo, insurance accepted for weight loss meds
  • Ongoing video visits, dedicated provider, labs and messaging from $59/mo
  • 1M+ patients treated with 95% patient satisfaction
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Our Top Choice
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
Visit TrimRx

About This Comparison

Our Editorial Standards

This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 9, 2026
Licensed Providers OnlyAll listed services are US-licensed

Weight Loss Telehealth in Delaware: 14 Providers Compared for 2026

Eric GoldWritten by Eric GoldEditor-in-Chief
19 min readUpdated October 9, 2026

Table of Contents

14 weight loss telehealth providers serve Delaware in 2026. Compare compounded semaglutide from $99/mo, insurance options, and top-rated platforms for DE residents.

Who Actually Operates in Delaware (and Who Doesn't)

If you've been searching for weight loss telehealth in Delaware, here's the straightforward answer: 14 providers are available to you right now. That's a solid number, and it gives you real options across price points, medication types, and levels of support. Clinic Secret, Nurx, and UrWay Health are not among the platforms compared on this page, so if you've seen those mentioned elsewhere online, check their own sites directly rather than relying on this guide for them.
The 14 providers serving Delaware in 2026 are TrimRx, Medvi, Ro, Strut, Shed, Fridays, Eden, HealthRx, Sprout Health, Peter MD, Skinny.Rx, Hers, Hims, and Sesame Care. That range covers everything from bare-bones budget platforms to full-service programs with nutritionist support and insurance navigation. The right one for you depends on whether you're paying out of pocket, whether you have insurance you want to use, and whether you want compounded or brand-name GLP-1 medication.
Delaware's regulatory environment for weight loss telehealth is relatively favorable compared to other states. Compounded semaglutide and compounded tirzepatide are both available through licensed 503B pharmacies, which matters mainly on price: brand-name Wegovy and Zepbound cost far more, even with the FDA shortages now declared resolved. You don't have to wait for a brand-name prescription to get started here.

Delaware's Insurance Parity Laws Change the Cost Equation

Delaware has full insurance parity for telehealth, meaning your insurer is required to cover an online doctor visit for weight loss at the same rate they'd cover an in-person visit. This is not the case in every state, and it's one of the most important facts a Delaware resident can know before signing up for anything. If you have employer-sponsored health insurance or a plan purchased through the Delaware marketplace, your initial consultation and follow-up visits with a telehealth provider may cost you nothing beyond your normal copay.
Delaware Medicaid also provides broader access to preventive care, including weight management services. If you're on Medicaid in Delaware, it's worth contacting your plan administrator directly before choosing a telehealth platform, because some services may be covered that you'd otherwise pay out of pocket for. Sesame Care accepts insurance for weight loss visits on a pay-per-visit basis, so it's a place to start if coverage is your priority.
Where insurance typically falls short is on the medication itself. Even with parity, most commercial insurance plans in Delaware cover Wegovy only under specific circumstances, usually requiring documentation of a BMI of 30 or higher, or a BMI of 27 or higher combined with a comorbidity like type 2 diabetes or hypertension. Ozempic gets covered more readily because it's labeled for diabetes, but using it off-label for weight loss is a different conversation with your insurer. Ro has built specific workflows to help with brand-name GLP-1 insurance navigation, which is why it's worth considering if you want Wegovy specifically and you have insurance that might cover it.

The Cheapest Weight Loss Programs Available to Delaware Residents

If cost is your main concern and you're paying out of pocket, start with Strut or HealthRx. Both offer compounded semaglutide at $99 per month, the lowest all-inclusive price available in Delaware, and that price includes the medication, the prescriber consultation, and shipping with no separate fees for the doctor visit or follow-up check-ins.
Eden starts at $129/month and Skinny.Rx prices compounded semaglutide from $149.25/month. Fridays is $150/month on its prepaid plan and $249/month month to month, and Shed starts at $159/month. Ro is $223/month all-in, and Hers and Hims are $298/month all-in once the membership each one requires is counted. All of these undercut Medvi on an ongoing basis: $179 is Medvi's first-month price, and refills run $299 per month after that, the highest recurring rate on this list; Medvi's free dietician visits and care coaching are the differentiator, not the price. If your first choice is waitlisted or has supply delays when you sign up, any of these platforms is a reasonable fallback, and the ones closest to the $99 floor are Eden and Skinny.Rx.
Sesame Care is worth mentioning for a different kind of cost savings. It's a pay-per-visit marketplace with transparent pricing and no subscription. If you already have a primary care doctor managing your weight loss but you just need a one-time telehealth consult or a prescription review, Sesame may cost you less than signing up for a monthly program. It doesn't bundle medication, but for Delaware residents who want flexibility over commitment, that trade-off can make sense.

Getting Semaglutide or Tirzepatide in Delaware: What's Actually Available

Delaware residents searching for semaglutide telehealth have access to both compounded and brand-name versions through the platforms listed here. Compounded semaglutide comes from FDA-registered 503B outsourcing facilities and is legal in Delaware on a prescription that records why you need the compounded form. Brand-name Wegovy and Ozempic supply has recovered, and the FDA declared the semaglutide shortage resolved in February 2025; a compounded formulation stays a significantly cheaper route if you qualify on that documented clinical basis.
Tirzepatide follows the same pattern. Compounded tirzepatide is available through several Delaware-accessible platforms, while brand-name Zepbound is available but less consistently stocked. Tirzepatide tends to produce stronger weight loss outcomes on average in clinical data, and the compounded version brings the monthly cost down enough that it's become a popular choice. Medvi and Sprout Health both offer tirzepatide options that ship to Delaware addresses.
The clinical threshold you need to meet is a BMI of 30 or higher without any additional health conditions, or a BMI of 27 or higher if you have a comorbidity like high blood pressure, high cholesterol, sleep apnea, or type 2 diabetes. Delaware telehealth providers follow this standard, and you'll answer questions about your health history during the intake process. Most platforms give you a decision within 24 to 48 hours of completing your consultation. If you're on the borderline at BMI 27 to 29, be thorough when listing comorbidities during intake because it directly affects approval.

Can You Get Phentermine Online in Delaware?

This is one of the most searched weight loss questions from Delaware, and the answer is yes, but with caveats. Phentermine is a Schedule IV controlled substance, and federal regulations governing how controlled substances can be prescribed via telehealth have been in a state of ongoing adjustment since the COVID-era flexibilities began expiring. As of 2026, some telehealth platforms will prescribe phentermine to Delaware residents after an initial evaluation, but not all of them do, and the ones that do typically require more documentation than they would for a non-controlled medication.
Phentermine is a shorter-term appetite suppressant, typically used for 12 weeks at a time, and it works differently from GLP-1 medications like semaglutide. It's significantly cheaper, often under $30 per month for the generic, and it's been prescribed for weight loss for decades. If you're looking for phentermine specifically, Peter MD is among the Delaware-accessible platforms most likely to offer it as part of a broader weight loss plan.
One practical thing to know: because phentermine is a controlled substance, you may be required to have a synchronous (live video) consultation rather than an asynchronous text-based intake before it can be prescribed. That's a telehealth prescribing requirement tied to federal DEA rules, not a Delaware-specific rule, but it means your first appointment will need to happen over video rather than just filling out a form.

Top-Rated Weight Loss Platforms for Delaware in 2026

Peter MD holds the highest rating among the 14 Delaware-available providers at 9.5 out of 10. Medvi and Hims serve very different needs; Medvi is rated 9.2 out of 10 and Hims 9.4 out of 10. Medvi is a pure weight loss specialist built around compounded semaglutide, priced at $179 for your first month and $299 per month for refills after that; Strut and HealthRx are the lowest price point in Delaware at $99 per month all-inclusive. Hims is a much broader platform that covers weight loss alongside ED, hair loss, and mental health, and it has a strong mobile app. If weight loss is your only goal and you want a platform that does nothing else, Medvi is the cleaner choice, though at $299 per month for refills it is the most expensive ongoing program on this page. If you want a platform you'll use for other health needs too, Hims makes more sense.
Ro earns a 9.3 rating and is one of the most significant options for Delaware residents who want brand-name GLP-1s like Wegovy or Ozempic rather than compounded versions. Ro has built specific infrastructure for working with insurance companies to get brand-name GLP-1s covered, which is meaningful in Delaware given the state's full insurance parity. If you have insurance and want to try to get Wegovy covered, Ro's workflow is more developed for that process than most other platforms here.
For women in Delaware specifically, Hers is the most purpose-built option on the list. It holds a 9.1 rating and covers weight loss alongside women's health concerns including hormonal health, mental health, and birth control. Because Delaware's full insurance parity covers online women's health visits, some Hers consultations may fall under your existing insurance coverage. For men looking at a full health picture that includes weight loss alongside ED or testosterone concerns, Peter MD covers all of those in one place with physician-led protocols.

Weight Loss Programs in Delaware That Offer More Than Just Medication

GLP-1 medications work best when combined with behavioral changes, and a few of the Delaware-available platforms build that support into their model. A few of the Delaware-available platforms build coaching into the medication program rather than just dispensing a prescription, which is worth prioritizing if you're new to weight loss telehealth. Sprout Health includes nutritionist support as part of its personalized care plans, and Shed layers in behavioral coaching alongside its compounded GLP-1 prescriptions. If you've tried medication before without results, or if you want accountability alongside the prescription, either is worth comparing directly.
Sprout Health also includes nutritionist support as part of its personalized care plans. It operates in Delaware with compounded GLP-1 options and a higher-touch care model. The 9.0 rating is solid, and the nutritionist access is a meaningful add-on that most budget platforms don't include. Shed adds behavioral coaching to its compounded GLP-1 platform as well.
If you have a diabetes diagnosis or a strong family history of metabolic disease, mention it during your intake so your prescriber can factor that into which medication and dosing plan they recommend. Ro specializes in working directly with insurance for Ozempic and other GLP-1s and approaches weight loss as a metabolic health question when your diagnosis supports it. If your doctor has mentioned prediabetes, insulin resistance, or metabolic syndrome, Ro frames the request in a way that may make more clinical sense to your insurer than a generic weight loss platform application.

Paying Out of Pocket in Delaware: What the Numbers Actually Look Like

If you're uninsured or your insurance doesn't cover weight loss medications, Delaware's access to compounded GLP-1s means you're not priced out of effective treatment. The cash-pay landscape in Delaware currently ranges from about $99 per month at the low end with Strut and HealthRx to $300 or more per month for platforms with heavier coaching and support. Brand-name Wegovy without insurance can run $1,300 to $1,500 per month at retail, which is why compounded semaglutide at $99 to $299 is such a significant alternative for uninsured Delaware residents.
Here's a realistic monthly cost breakdown for uninsured Delaware residents based on current platform pricing: Strut and HealthRx run $99 all-inclusive. Skinny.Rx runs $149.25 and Shed runs $159, in a similar range with coaching included. Hers and Hims run $298 all-in once the membership each one requires is counted. Medvi runs $179 for your first month and $299 per month for refills after that, all-inclusive, with free dietician visits and care coaching included. Ro, Sprout Health, and Hims vary depending on whether you're getting compounded or brand-name medication, but compounded options through those platforms typically land in the $200 to $350 range once you factor in all fees. Sesame Care bills insurance when available, but its out-of-pocket consultation fee is relatively modest as a pay-per-visit model.
One thing worth knowing if you're cash-paying in Delaware: always ask the platform whether their quoted price includes medication, the consultation fee, and shipping, or whether those are billed separately. Some platforms advertise a low monthly rate but charge separately for the initial consultation or for shipping. Medvi is clear about all-inclusive pricing, which makes comparison easier. Sesame Care's pay-per-visit model also avoids subscription lock-in entirely, which some Delaware residents prefer if they want to test a platform before committing.

Why Compounded GLP-1s Are Legal in Delaware and What That Means for You

Delaware residents sometimes wonder whether compounded semaglutide or tirzepatide is actually legal, or whether they're doing something legally gray by ordering it. The short answer is that compounded GLP-1 medications are legally available in Delaware through licensed 503B outsourcing facilities, which are regulated by the FDA. These are not underground pharmacies. They operate under federal oversight, and the compounded medication they produce is dispensed through licensed prescribers using the same active pharmaceutical ingredient as brand-name Wegovy or Ozempic.
The reason compounded versions exist and remain available in Delaware is that FDA policy allows compounding when a drug sits on the official shortage list, or when your prescriber documents a clinical need the brand-name product does not meet. Semaglutide and tirzepatide sat on those lists until the FDA closed them in February 2025 and December 2024, which leaves the second route as the one Delaware prescriptions run on now. When a platform serving Delaware offers you a compounded GLP-1, ask which pharmacy fills it and whether that pharmacy is a 503A or a 503B facility, since the two are regulated differently.
What this means practically for you is that if a Delaware telehealth provider prescribes you compounded semaglutide, the medication you receive is a legitimate pharmaceutical product, not a knockoff. The dose titration protocol should be the same as what you'd follow on brand-name Wegovy. The main things you're giving up with compounded are the branded packaging, the branded pen device, and the direct manufacturer warranty on purity that comes with an FDA-approved product. For most Delaware residents paying out of pocket, that trade-off is worth $1,000 or more per month in savings.

Frequently Asked Questions

How many weight loss telehealth providers are available in Delaware right now?

As of 2026, 14 weight loss telehealth providers operate in Delaware. They are TrimRx, Medvi, Ro, Strut, Shed, Fridays, Eden, HealthRx, Sprout Health, Peter MD, Skinny.Rx, Hers, Hims, and Sesame Care. Three providers that are sometimes mentioned online do not serve Delaware: Clinic Secret, Nurx, and UrWay Health. Peter MD holds the highest rating among the 14 available platforms at 9.5 out of 10. Medvi is rated 9.2 out of 10 and Hims 9.4 out of 10. Your best starting point depends on whether you're paying out of pocket, whether you have insurance you want to use, and whether you're looking for compounded or brand-name GLP-1 medication.

Is Ro available in Delaware for Wegovy or Ozempic?

Yes, Ro is fully available in Delaware and is one of the better options if you want brand-name Wegovy or Ozempic rather than a compounded alternative. Ro holds a 9.3 rating and has built specific workflows to help with insurance navigation for brand-name GLP-1s. Because Delaware has full insurance parity for telehealth visits, your consultation with Ro may be covered by your insurance at the same rate as an in-person visit. Ro also covers compounded GLP-1 options for Delaware residents who don't have coverage for brand-name medications. If your goal is to try to get Wegovy covered by insurance, Ro is one of the most developed platforms for that process among the Delaware-available options.

What is the cheapest weight loss medication program available in Delaware?

Strut and HealthRx are the most affordable all-inclusive weight loss programs available in Delaware in 2026, both priced at $99 per month for compounded semaglutide. That price covers the medication, the prescriber consultation, and shipping with no separate fees. Skinny.Rx starts at $149.25/month and Shed starts at $159/month, and Hers and Hims run $298/month all-in once the membership each one requires is counted. All of them come in under Medvi, which is $179 for your first month and $299/month for refills after that, the highest ongoing price on this page; Medvi holds a 9.2 rating and its free dietician visits and care coaching are the differentiator, not the price. If you have insurance, Sesame Care may reduce your out-of-pocket costs further by billing your plan for consultations. Delaware's full insurance parity means telehealth visit costs may be covered at in-person rates, which can bring your effective monthly cost lower depending on your plan.

Can I get phentermine prescribed online in Delaware?

Yes, phentermine can be prescribed online in Delaware, but the process has more requirements than non-controlled weight loss medications. Phentermine is a Schedule IV controlled substance, which means federal DEA rules require a synchronous video consultation before it can be prescribed via telehealth rather than a simple text-based intake form. Once that live video visit happens, eligible Delaware residents can receive a prescription. Platforms most likely to offer phentermine to Delaware residents include Peter MD. Generic phentermine is typically under $30 per month at the pharmacy, making it the most affordable medication option if you qualify. It's generally used for 12-week courses rather than long-term, unlike GLP-1 medications.

Does Delaware insurance cover weight loss telehealth visits and medications?

Delaware has full insurance parity for telehealth, meaning your insurer must cover an online weight loss consultation at the same rate as an in-person visit. This applies to commercial insurance plans and marketplace plans in Delaware. The consultation cost may be nothing beyond your standard copay. Medication coverage is a separate question. Most commercial plans in Delaware cover Wegovy only if you have a BMI of 30 or higher, or a BMI of 27 or higher with a documented comorbidity like hypertension or type 2 diabetes. Ozempic gets covered more readily for people with diabetes diagnoses. Compounded semaglutide is not covered by insurance in Delaware. If getting insurance coverage for brand-name GLP-1s is your goal, Ro has the most developed process for working with insurers in Delaware.

Is compounded semaglutide legal in Delaware?

Yes, compounded semaglutide is legal in Delaware when dispensed through a licensed 503B outsourcing facility under a valid prescription from a licensed provider. These facilities are federally regulated by the FDA and operate under pharmaceutical manufacturing standards. The active ingredient is the same as Wegovy or Ozempic, and the medication is dispensed in clinical doses. With both shortage listings closed since early 2025, what keeps compounded versions available in Delaware is the other half of that policy: a specific clinical need the brand-name version cannot cover, written into your record at the time of prescribing. Before you start with any Delaware platform, get the name of the pharmacy that fills your prescription and check which of the two categories it falls under. The practical benefit for Delaware residents is that compounded semaglutide can cost $99 to $299 per month versus $1,300 or more for brand-name Wegovy without insurance.

What weight loss medications can online doctors in Delaware prescribe?

Online doctors serving Delaware can prescribe a solid range of weight loss medications. GLP-1 options include compounded semaglutide, brand-name Wegovy, Ozempic for qualifying diabetes patients, compounded tirzepatide, and brand-name Zepbound. Non-GLP-1 options include liraglutide, phentermine (with a video consultation requirement due to its controlled status), metformin for insulin resistance and weight management, and bupropion-naltrexone, which is the combination used in Contrave. The clinical standard for qualifying in Delaware is a BMI of 30 or higher without comorbidities, or a BMI of 27 or higher with at least one weight-related health condition. Most telehealth platforms serving Delaware use an online intake form and a brief provider review to determine which medication is appropriate for your profile.

Which Delaware weight loss platform is best for someone who wants coaching and not just medication?

A few of Delaware's available platforms build coaching in alongside medication, which is a good starting point if you want lifestyle coaching included. Sprout Health includes nutritionist support in its personalized care plans and operates in Delaware with compounded GLP-1 options. Shed adds behavioral coaching to its compounded GLP-1 program as well. If your history includes trying medication without lasting results, a platform that builds behavioral support into the model tends to produce better long-term outcomes than medication alone. For Delaware Medicaid recipients, contact your plan administrator first, as some supportive services may already be covered.

Is Henry Meds a good option for weight loss in Delaware?

Henry Meds is not one of the platforms compared on this page, so check Henry Meds directly for current Delaware availability. If you have a diabetes diagnosis, prediabetes, insulin resistance, or metabolic syndrome, several Delaware-available platforms, including Ro, work directly with insurance for Ozempic and can factor a metabolic diagnosis into coverage. Ro has the infrastructure to help navigate that coverage if your insurer covers Ozempic for diabetes. Delaware's full insurance parity means the consultation itself may be covered by your plan at no extra cost. If you don't have a metabolic health condition and you're looking purely at weight loss, Medvi or Hims are likely better fits.

How does Delaware's telehealth access for weight loss compare to neighboring states?

Delaware is one of the better states for weight loss telehealth access in the Mid-Atlantic region. Full insurance parity means your online consultations are treated the same as in-person visits for billing purposes, which not every neighboring state guarantees. Delaware Medicaid also provides broader access to preventive care including weight management services. Compounded GLP-1s are available here through licensed 503B pharmacies, giving Delaware residents access to medication at $99 to $299 per month rather than $1,300 or more for brand-name alternatives. Phentermine is prescribable via telehealth in Delaware with proper video consultation, which some states have restricted more tightly. The combination of insurance parity, Medicaid access, compounded medication availability, and 14 active platforms makes Delaware a relatively well-served state for weight loss telehealth in 2026.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

  • America's Health Rankings - Obesity in DelawareDelaware adult obesity prevalence data from the CDC Behavioral Risk Factor Surveillance System.
  • NIDDK - Weight ManagementNIDDK evidence-based guidance on weight management: BMI thresholds, GLP-1 medications, and health risks of obesity.
  • CCHP Telehealth Policy - DelawareDelaware state telehealth laws, online prescribing rules, and insurance reimbursement policies maintained by the Center for Connected Health Policy.
  • CDC - Adult Obesity FactsCDC data: over 40% of U.S. adults have obesity, with $173 billion in annual medical costs. National prevalence and demographic breakdowns.
  • America's Health Rankings - Diabetes in DelawareDelaware diabetes prevalence among adults, sourced from CDC BRFSS data.
  • America's Health Rankings - Cardiovascular Health in DelawareDelaware cardiovascular disease prevalence, including heart attack, stroke, and coronary heart disease.
  • NIMH - Mental Illness StatisticsNIMH data: 1 in 5 U.S. adults experience mental illness annually. National prevalence by condition, age, and demographic.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
Visit TrimRx

Compare Top Weight Loss Providers

See how the top weight loss providers in Delaware stack up against each other:

Ro vs MedviRo vs StrutRo vs FridaysView All Comparisons →

More Telehealth Options in Delaware

Explore other telehealth treatments available in Delaware:

Erectile Dysfunction in DelawareHair Loss in DelawareWomens Health in DelawarePremature Ejaculation in DelawareMental Health in DelawareWeight Loss NationwideGLP-1 Price Index 2026How to Get Ozempic Without Insurance (2026 Guide)All Delaware TreatmentsBrowse All States →
Eric Gold
Eric GoldEditor-in-Chief

Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

Medical Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Telehealth regulations in Delaware may change. Always verify requirements with your chosen provider. Read our full medical disclaimer.

Regulatory noticeRegulatory note (verified October 8, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that site copy presenting the compounded drug as having the same active ingredient as Wegovy and Ozempic, and as Mounjaro and Zepbound, implied an FDA approval compounded drugs do not have. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for MEDVi, LLC on October 8, 2026 it showed no response letter and no close-out letter entered against it, so the letter is not closed out on the public record. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter

Regulatory noticeRegulatory note (verified October 8, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. The letter also quotes three claims from the site, among them "Generic Zepbound, Mounjaro", along with site copy naming semaglutide and tirzepatide as the active ingredient in the brand medications. Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for Strut Health, LLC on October 8, 2026 it showed no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): One sentence is all that FDA warning letter MARCS-CMS 715879 quotes. Sent to Sprout Health Partners LLC on September 9, 2025 after an August 2025 review of joinsprouthealth.com, it cites the line "GLP-1 medications are FDA-approved and backed by extensive clinical research..." Appearing on pages offering compounded semaglutide and tirzepatide, that statement implied to the agency that the compounded products themselves are FDA-approved, which they are not, and it was cited as misbranding under FD&C Act 502(a) and 502(bb). A search of FDA’s warning letter index turns up no close-out letter, so the matter appears open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Eden Health International Inc. was sent FDA warning letter MARCS-CMS 728279 on June 8, 2026, following an agency review of tryeden.com in March 2026. The letter lists two findings. The first is the "Eden" name on pictured labels for compounded semaglutide and tirzepatide, which the FDA said represents Eden as the compounder when it is not. The second is the site’s description of its sourcing as "FDA-licensed 503(a) outsourcing facilities," a designation the agency says does not exist, because the FD&C Act creates no FDA approval or license for pharmacies or outsourcing facilities. Both were cited as misbranding under sections 502(a) and 502(bb). FDA has posted no close-out letter, so the matter reads as open. Read the FDA letter

Verification limitationVerification note (checked August 23, 2026): we could not identify the legal entity behind HealthRx through public records. Its website does not name an operating company, its domain registration is privacy-shielded, and we could not confirm a listing in any business registry or accreditation database we checked. This is not a finding of wrongdoing. It means our usual checks, including our search of FDA enforcement records, could only be run against the brand name and domain rather than a confirmed company.

Regulatory noticeRegulatory note (verified August 22, 2026): Skinny.Rx operates as SkinnyRx, but the legal entity is Lean Rx, Inc., and that is the name on FDA warning letter MARCS-CMS 717989, dated February 20, 2026. Following a December 2025 review of skinnyrx.com, the agency objected to the "SkinnyRx" name on pictured labels, saying it implies SkinnyRx compounds the drugs itself, and to three marketing lines, including "Get access to the same active ingredient as name-brand GLP-1 medications" and "It contains the same active ingredient as FDA-approved medications." Compounded semaglutide and tirzepatide are not FDA-approved, so the FDA read those lines as implying an approval that does not exist and classed the products as misbranded. FDA's warning letter index carries no close-out letter for MARCS-CMS 717989, so read the matter as unresolved. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter